APA (7th ed.) Citation

C, T., S, S., N, T., F, B., M, M., S, B., . . . P, L. (2026). Real-Life Effectiveness After Switching to Avalglucosidase Alfa in Late-Onset Pompe Disease Patients Worsening on Alglucosidase Alfa Therapy: A French Cohort Study. European journal of neurology, 33(7), e70680. https://doi.org/10.1111/ene.70680

Chicago Style (17th ed.) Citation

C, Tard, et al. "Real-Life Effectiveness After Switching to Avalglucosidase Alfa in Late-Onset Pompe Disease Patients Worsening on Alglucosidase Alfa Therapy: A French Cohort Study." European Journal of Neurology 33, no. 7 (2026): e70680. https://doi.org/10.1111/ene.70680.

MLA (9th ed.) Citation

C, Tard, et al. "Real-Life Effectiveness After Switching to Avalglucosidase Alfa in Late-Onset Pompe Disease Patients Worsening on Alglucosidase Alfa Therapy: A French Cohort Study." European Journal of Neurology, vol. 33, no. 7, 2026, p. e70680, https://doi.org/10.1111/ene.70680.